Brief: Cellvizio Obtains Positive Assessment From The Korean NECA
March 15 (Reuters) - Mauna Kea Technologies SAS MKEA.PA :
* CELLVIZIO® OBTAINS POSITIVE ASSESSMENT FROM THE KOREAN
NATIONAL
EVIDENCE-BASED HEALTHCARE COLLABORATING AGENCY (NECA)
Source text for Eikon: ID:nBw5jlBtVa
Further company coverage: MKEA.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mauna Kea Technologies SA
See all newsBrief: Mauna Kea Technologies Confirms Trajectory Toward Profitability By Year-End 2027
Brief: Mauna Kea Technologies Announces Results Of Its Combined General Meeting
French and Benelux stocks-Factors to watch 21 Nov
Brief: Mauna Kea Technologies Receives NMPA Regulatory Approval In China For Its Next-Generation Cellvizio Platform
Europe Research Roundup: Craneware, Croda, Genus